Conclusion of a non-exclusive discount agreement according to § 130a para. 8 SGB V for the active ingredient Natalizumab (exclusively infusion solution concentrate), ATC L04AG03 for the period 01.12.2026 - 30.11.2028
🔍 Key Information
📄
Tender Reference No.
101767949
📅
Publication Date
16 Oct 2026
💰
Estimated Value
N/A
🌐
Sector
N/A
📅
Deadline
05 Oct 2028
📝
Notice Type
Tenders
📍
Location
Germany
📑
Contract Duration
1 Year 11 Months 19 Days
📁
Documents & Downloads
No documents found
🏷️ CPV
No CPV found
Need help with this bid?
Our bid experts can help you find, evaluate & win more tenders.
